| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,465 |
7,134 |
$642K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,948 |
3,548 |
$367K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,750 |
2,485 |
$274K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,889 |
1,702 |
$262K |
| 86769 |
|
4,475 |
2,112 |
$153K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
361 |
313 |
$131K |
| 87481 |
|
1,106 |
1,028 |
$99K |
| 87581 |
|
2,896 |
2,579 |
$91K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
720 |
703 |
$85K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
676 |
657 |
$84K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,100 |
1,037 |
$57K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,761 |
1,692 |
$50K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,081 |
2,941 |
$48K |
| 80061 |
Lipid panel |
3,548 |
3,398 |
$44K |
| 84481 |
|
2,729 |
2,609 |
$43K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,287 |
1,234 |
$42K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,286 |
1,234 |
$42K |
| 84403 |
|
1,708 |
1,630 |
$40K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,173 |
1,096 |
$39K |
| 87500 |
|
1,070 |
1,024 |
$36K |
| 87641 |
|
1,071 |
1,025 |
$36K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
704 |
647 |
$35K |
| 80053 |
Comprehensive metabolic panel |
3,418 |
3,282 |
$33K |
| 82670 |
|
925 |
882 |
$24K |
| 83970 |
|
575 |
554 |
$23K |
| 84439 |
|
2,735 |
2,614 |
$23K |
| 82607 |
|
1,316 |
1,276 |
$19K |
| 83002 |
|
1,029 |
985 |
$18K |
| 82746 |
|
1,220 |
1,182 |
$17K |
| 82533 |
|
1,057 |
1,012 |
$16K |
| 83540 |
|
2,537 |
2,419 |
$15K |
| 83001 |
|
739 |
707 |
$13K |
| 84154 |
|
775 |
732 |
$13K |
| 84153 |
|
752 |
711 |
$12K |
| 82728 |
|
919 |
891 |
$12K |
| 84144 |
|
557 |
535 |
$11K |
| 99215 |
Prolong outpt/office vis |
65 |
63 |
$10K |
| 84146 |
|
559 |
541 |
$10K |
| 84270 |
|
284 |
272 |
$6K |
| 87507 |
|
16 |
16 |
$6K |
| 99385 |
|
41 |
41 |
$6K |
| 82677 |
|
407 |
254 |
$5K |
| 82627 |
|
200 |
191 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
37 |
37 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
381 |
373 |
$3K |
| 87650 |
|
126 |
123 |
$2K |
| 87653 |
|
59 |
46 |
$2K |
| 0011A |
|
39 |
37 |
$1K |
| 93000 |
|
93 |
88 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
30 |
30 |
$1K |
| 93922 |
|
12 |
12 |
$953.99 |
| 87529 |
|
41 |
19 |
$811.63 |
| 87631 |
|
38 |
24 |
$806.60 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
18 |
13 |
$792.24 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
82 |
80 |
$727.57 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
57 |
29 |
$655.56 |
| 99442 |
|
59 |
57 |
$622.30 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
14 |
14 |
$587.60 |
| 99441 |
|
12 |
12 |
$74.10 |